Julia E Heck1,2, Di He1, Carla Janzen3, Noah Federman4, Jorn Olsen5, Beate Ritz1, Johnni Hansen6. 1. Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, California. 2. Jonsson Comprehensive Cancer Center, University of California, Los Angeles, California. 3. Department of Obstetrics and Gynecology, Geffen School of Medicine, University of California, Los Angeles, California. 4. Department of Pediatrics, Geffen School of Medicine, University of California, Los Angeles, California. 5. Department of Clinical Epidemiology, Aarhus University, Aarhus, Denmark. 6. Danish Cancer Society Research Center, Copenhagen, Denmark.
Abstract
BACKGROUND: The "fetal programming" hypothesis has been evaluated in many adult diseases including cancer, but not for Wilms tumor. Wilms tumor has been related to high birthweight, but little is known about other growth metrics such as a baby's birth length, ponderal index, or placenta size, which can shed additional light on growth patterns. METHODS: Cases of Wilms tumor (N = 217) were taken from the Danish Cancer Registry, and controls (N = 4340) were randomly selected from the Population Register and matched to cases by sex and age. Linkage to the Medical Births Registry provided information on gestational factors and fetal growth measurements, while linkage to the Patient Register provided information on maternal and child health conditions. RESULTS: Despite having typically normal to higher birthweights, Wilms tumor cases had smaller placentas (≤540 g; odds ratio (OR) = 4.24; 95% confidence interval (CI), 1.84-9.78) and a lower placenta-to-birthweight ratio (OR = 1.81; 95% CI, 1.17-2.82, per 1 SD decrease). Small placentas were more common among Wilms cases without congenital anomalies (OR = 6.43; 95% CI, 1.95-21.21). Wilms tumor cases had a higher prevalence of high birthweight (>4000 g; OR = 1.57; 95% CI, 1.11-2.22), birth length 55 cm or longer (OR = 1.74; 95% CI, 1.09-2.78), and being large for gestational age (OR = 1.79; 95% CI, 1.08-2.96). CONCLUSIONS: Our study corroborates earlier studies showing associations with high birthweight and suggests associations between Wilms tumor and decreased placental size and low placenta-to-birthweight ratio.
BACKGROUND: The "fetal programming" hypothesis has been evaluated in many adult diseases including cancer, but not for Wilms tumor. Wilms tumor has been related to high birthweight, but little is known about other growth metrics such as a baby's birth length, ponderal index, or placenta size, which can shed additional light on growth patterns. METHODS: Cases of Wilms tumor (N = 217) were taken from the Danish Cancer Registry, and controls (N = 4340) were randomly selected from the Population Register and matched to cases by sex and age. Linkage to the Medical Births Registry provided information on gestational factors and fetal growth measurements, while linkage to the Patient Register provided information on maternal and child health conditions. RESULTS: Despite having typically normal to higher birthweights, Wilms tumor cases had smaller placentas (≤540 g; odds ratio (OR) = 4.24; 95% confidence interval (CI), 1.84-9.78) and a lower placenta-to-birthweight ratio (OR = 1.81; 95% CI, 1.17-2.82, per 1 SD decrease). Small placentas were more common among Wilms cases without congenital anomalies (OR = 6.43; 95% CI, 1.95-21.21). Wilms tumor cases had a higher prevalence of high birthweight (>4000 g; OR = 1.57; 95% CI, 1.11-2.22), birth length 55 cm or longer (OR = 1.74; 95% CI, 1.09-2.78), and being large for gestational age (OR = 1.79; 95% CI, 1.08-2.96). CONCLUSIONS: Our study corroborates earlier studies showing associations with high birthweight and suggests associations between Wilms tumor and decreased placental size and low placenta-to-birthweight ratio.
Authors: Zuelma A Contreras; Johnni Hansen; Beate Ritz; Jorn Olsen; Fei Yu; Julia E Heck Journal: Cancer Epidemiol Date: 2017-07-14 Impact factor: 2.984
Authors: Kate A O'Neill; Michael Fg Murphy; Kathryn J Bunch; Susan E Puumala; Susan E Carozza; Eric J Chow; Beth A Mueller; Colleen C McLaughlin; Peggy Reynolds; Tim J Vincent; Julie Von Behren; Logan G Spector Journal: Int J Epidemiol Date: 2015-01-27 Impact factor: 7.196
Authors: Hans T Bjornsson; Lindsey J Brown; M Danielle Fallin; Michael A Rongione; Marina Bibikova; Eliza Wickham; Jian-Bing Fan; Andrew P Feinberg Journal: J Natl Cancer Inst Date: 2007-08-08 Impact factor: 13.506
Authors: Julia E Heck; Xiwen Huang; Kara L Calkins; Yuelian Sun; Jorn Olsen; Beate Ritz; Johnni Hansen Journal: Int J Cancer Date: 2019-11-04 Impact factor: 7.396
Authors: Åsa Magnusson; Hannele Laivuori; Anne Loft; Nan B Oldereid; Anja Pinborg; Max Petzold; Liv Bente Romundstad; Viveca Söderström-Anttila; Christina Bergh Journal: Front Pediatr Date: 2021-06-23 Impact factor: 3.418